Ignite Creation Date:
2025-12-24 @ 4:26 PM
Ignite Modification Date:
2026-02-24 @ 10:54 AM
Study NCT ID:
NCT02365766
Status:
COMPLETED
Last Update Posted:
2025-03-18
First Post:
2015-02-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
Sponsor:
Jason R. Brown
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HCRN GU14-188
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None